Table 4.
Relationship between virulence genes and antimicrobial resistance patterns in all C. jejuni tested.
| Virulence gene | Number (percentage) of isolates resistant to: | |||
|---|---|---|---|---|
| CIP (n = 577) | NAL (n = 555) | STR (n = 115) | TET (n = 427) | |
|
flaA+ (n = 617) flaA− (n = 7) |
570 (92.4) 7 (100) |
548 (88.8) 7 (100) |
114 (18.5) 1 (14.3) |
425 (68.9)* 2 (28.6) |
|
flhA+ (n = 618) flhA− (n = 6) |
571 (92.4) 6 (100) |
549 (88.9) 6 (100) |
115 (18.6) 0 |
425 (68.8) 2 (33.3) |
|
cadF+ (n = 631) cadF− (n = 3) |
574 (91.0) 3 (100) |
552 (87.5) 3 (100) |
115 (18.2) 0 |
425 (67.3) 2 (66.7) |
|
docA+ (n = 616) docA− (n = 8) |
569 (93.4) 8 (100) |
547 (88.8) 8 (100) |
113 (18.3) 2 (25.0) |
421 (68.3) 6 (75.0) |
|
racR+ (n = 611) racR− (n = 13) |
565 (92.5) 12 (92.3) |
543 (88.9) 12 (92.3) |
115 (18.8) 0 |
421 (68.9) 6 (46.1) |
|
virB11+ (n = 12) virB11− (n = 612) |
10 (83.3) 567 (92.6) |
10 (83.3) 545 (89.0) |
0 0 |
9 (75.0) 418 (68.3) |
|
cdtA+ (n = 603) cdtA− (n = 21) |
556 (92.2) 21 (100) |
542 (89.9)*** 13 (61.9) |
104 (17.2)*** 11 (52.4) |
411 (68.2) 16 (76.2) |
|
cdtB+ (n = 603) cdtB− (n = 21) |
556 (92.2) 21 (100) |
541 (89.7)*** 14 (66.7) |
106 (17.6)** 9 (42.9) |
414 (68.7) 13 (61.9) |
|
cdtC+ (n = 609) cdtC− (n = 15) |
562 (92.3) 15 (100) |
546 (89.6)*** 9 (60.0) |
109 (17.9)* 6 (40.0) |
417 (68.5) 10 (66.7) |
|
wlaN+ (n = 95) wlaN− (n = 529) |
87 (91.6) 490 (92.6) |
87 (91.6) 468 (88.5) |
6 (6.3)*** 109 (20.6) |
54 (56.8)** 373 (70.5) |
|
ciaB+ (n = 614) ciaB− (n = 10) |
567 (92.3) 10 (100) |
545 (88.8) 10 (100) |
114 (18.6) 1 (10.0) |
421 (68.6) 6 (60.0) |
|
iam+ (n = 128) iam− (n = 496) |
118 (92.2) 459 (92.5) |
115 (89.8) 440 (88.7) |
15 (11.7) 100 (20.2) |
83 (64.8) 344 (69.3) |
|
sodB+ (n = 620) sodB− (n = 4) |
573 (92.4) 4 (100) |
551 (88.9) 4 (100) |
113 (18.2) 2 (50.0) |
425 (68.5) 2 (50.0) |
CIP, ciprofloxacin; NAL, nalidixic acid; STR, streptomycin; TET, tetracycline;
*
P < 0.05;
**
P < 0.01;
***
P < 0.001.